[ENDOCRINE CHANGES OBSERVED IN PATIENTS UNDER TREATMENT WITH TRIFLUOPERAZINE].
D015068:17-Ketosteroids; D000293:Adolescent; D000305:Adrenal Cortex Hormones; D000324:Adrenocorticotropic Hormone; D000568:Amenorrhea; D001940:Breast; D005260:Female; D005640:Follicle Stimulating Hormone; D006177:Gynecomastia; D006801:Humans; D007775:Lactation Disorders; D008297:Male; D008660:Metabolism; D010858:Pigmentation; D011388:Prolactin; D012559:Schizophrenia; D014116:Toxicology; D014268:Trifluoperazine; D014556:Urine
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D014268:Trifluoperazine; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D005640:Follicle Stimulating Hormone
17-KETOSTEROIDS; ADOLESCENCE; ADRENAL CORTEX HORMONES; AMENORRHEA; BREAST; CORTICOTROPIN; FSH; GYNECOMASTIA; LACTATION DISORDERS; METABOLISM; PIGMENTATION; PROLACTIN; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRIFLUOPERAZINE; URINE
ALTERACIONES END'OCRINAS OBSERVADAS EN PACIENTES BAJO TRATAMIENTO CON TRIFLUOPERAZINA.